These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31066253)

  • 1. Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression.
    Vahidi Manesh P; Farazmand A; Gharibdoost F; Vanaki N; Mostafaei S; Kavosi H; Mahmoudi MB; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):173-181. PubMed ID: 31066253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients.
    Ebrahimiyan H; Gharibdoost F; Aslani S; Kavosi H; Farsad F; Jamshidi A; Mahmoudi M
    Mod Rheumatol; 2020 Sep; 30(5):862-869. PubMed ID: 31441344
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
    Chouri E; Servaas NH; Bekker CPJ; Affandi AJ; Cossu M; Hillen MR; Angiolilli C; Mertens JS; van den Hoogen LL; Silva-Cardoso S; van der Kroef M; Vazirpanah N; Wichers CGK; Carvalheiro T; Blokland SLM; Giovannone B; Porretti L; Marut W; Vigone B; van Roon JAG; Beretta L; Rossato M; Radstake TRDJ
    J Autoimmun; 2018 May; 89():162-170. PubMed ID: 29371048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
    Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
    Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
    Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis.
    Jafarinejad-Farsangi S; Gharibdoost F; Farazmand A; Kavosi H; Jamshidi A; Karimizadeh E; Noorbakhsh F; Mahmoudi M
    Autoimmunity; 2019 May; 52(3):108-116. PubMed ID: 31155965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
    Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.
    Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
    Front Immunol; 2018; 9():449. PubMed ID: 29559981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1.
    Zhou B; Zhu H; Luo H; Gao S; Dai X; Li Y; Zuo X
    Biomed Pharmacother; 2017 Mar; 87():412-418. PubMed ID: 28068631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis.
    Mahmoudi MB; Farashahi Yazd E; Gharibdoost F; Sheikhha MH; Karimizadeh E; Jamshidi A; Mahmoudi M
    Ir J Med Sci; 2019 Nov; 188(4):1443-1449. PubMed ID: 30761457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis.
    Jafarinejad-Farsangi S; Farazmand A; Mahmoudi M; Gharibdoost F; Karimizadeh E; Noorbakhsh F; Faridani H; Jamshidi AR
    Autoimmunity; 2015; 48(6):369-78. PubMed ID: 25857445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
    Iwamoto N; Vettori S; Maurer B; Brock M; Pachera E; Jüngel A; Calcagni M; Gay RE; Whitfield ML; Distler JH; Gay S; Distler O
    Ann Rheum Dis; 2016 Jan; 75(1):303-10. PubMed ID: 25384965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis.
    Jafarinejad-Farsangi S; Farazmand A; Gharibdoost F; Karimizadeh E; Noorbakhsh F; Faridani H; Mahmoudi M; Jamshidi AR
    Int J Dermatol; 2016 Nov; 55(11):1259-1267. PubMed ID: 27637490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis.
    Kozlova A; Pachera E; Maurer B; Jüngel A; Distler JHW; Kania G; Distler O
    Arthritis Rheumatol; 2019 Dec; 71(12):2068-2080. PubMed ID: 31309742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
    Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
    Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis].
    Li WG; Gu XD; Weng RQ; Liu SD; Chen C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1022-1027. PubMed ID: 38101783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.
    Ciechomska M; O'Reilly S; Suwara M; Bogunia-Kubik K; van Laar JM
    PLoS One; 2014; 9(12):e115596. PubMed ID: 25549087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.
    Tanaka S; Suto A; Ikeda K; Sanayama Y; Nakagomi D; Iwamoto T; Suzuki K; Kambe N; Matsue H; Matsumura R; Kashiwakuma D; Iwamoto I; Nakajima H
    Rheumatology (Oxford); 2013 Nov; 52(11):1963-72. PubMed ID: 23893664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis.
    Mokuda S; Miyazaki T; Ubara Y; Kanno M; Sugiyama E; Takasugi K; Masumoto J
    Arthritis Res Ther; 2015 Sep; 17():275. PubMed ID: 26419626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.